Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,487 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse.
Tinsley JM, Fairclough RJ, Storer R, Wilkes FJ, Potter AC, Squire SE, Powell DS, Cozzoli A, Capogrosso RF, Lambert A, Wilson FX, Wren SP, De Luca A, Davies KE. Tinsley JM, et al. Among authors: lambert a. PLoS One. 2011 May 6;6(5):e19189. doi: 10.1371/journal.pone.0019189. PLoS One. 2011. PMID: 21573153 Free PMC article.
Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy.
Chancellor DR, Davies KE, De Moor O, Dorgan CR, Johnson PD, Lambert AG, Lawrence D, Lecci C, Maillol C, Middleton PJ, Nugent G, Poignant SD, Potter AC, Price PD, Pye RJ, Storer R, Tinsley JM, van Well R, Vickers R, Vile J, Wilkes FJ, Wilson FX, Wren SP, Wynne GM. Chancellor DR, et al. J Med Chem. 2011 May 12;54(9):3241-50. doi: 10.1021/jm200135z. Epub 2011 Apr 15. J Med Chem. 2011. PMID: 21456623
Discovery and SAR of 2-arylbenzotriazoles and 2-arylindazoles as potential treatments for Duchenne muscular dystrophy.
De Moor O, Dorgan CR, Johnson PD, Lambert AG, Lecci C, Maillol C, Nugent G, Poignant SD, Price PD, Pye RJ, Storer R, Tinsley JM, Vickers R, Well Rv, Wilkes FJ, Wilson FX, Wren SP, Wynne GM. De Moor O, et al. Bioorg Med Chem Lett. 2011 Aug 15;21(16):4828-31. doi: 10.1016/j.bmcl.2011.06.047. Epub 2011 Jun 17. Bioorg Med Chem Lett. 2011. PMID: 21741236
Postnatal growth of etiologically characterized preterm newborns according to gestational age at birth.
Roggero P, Ryumina I, Gunier RB, Winsey A, Rauch SA, Zarco IAC, Ariff S, Rego MAS, Conti CS, Ochieng R, Tuzun F, Asibey J, Giuliani F, Renau MI, Shekharappa CB, Lapillonne A, Tavcioska G, Ismail LC, Menis C, Markelova M, Nieto R, Duah JA, Deantoni S, Madrid BF, Mosca F, Eskenazi B, Lambert A, Bhutta Z, Papageorghiou A, Kennedy S, Villar J. Roggero P, et al. Among authors: lambert a. Pediatr Res. 2024 Nov 28. doi: 10.1038/s41390-024-03735-x. Online ahead of print. Pediatr Res. 2024. PMID: 39609613
Endocrine management of transgender adolescents: Expert consensus of the french society of pediatric endocrinology and diabetology working group.
Brezin F, Busiah K, Leroy C, Fiot E, Bensignor C, Amouroux C, Caquard M, Cartault A, Castets S, Delcour C, Devernay M, Feigerlova E, Hoarau M, Lebon-Labich B, Lambert AS, Rouleau S, Trouvin MA, Vautier V, Martinerie L. Brezin F, et al. Among authors: lambert as. Arch Pediatr. 2024 Nov 16:S0929-693X(24)00176-3. doi: 10.1016/j.arcped.2024.08.003. Online ahead of print. Arch Pediatr. 2024. PMID: 39551654 Free article.
1,487 results